Skip to main content

Table 2 Multivariate analysis for OS and basal patient and disease characteristics

From: Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center

 HR95% CI for HRP value
InferiorSuperior
Triple negative2.3341.2154.4810.011
> 2 organs involvement2.2721.194.2740.013
Age (< 70 years old)2.3541.0705.1800.033
Visceral metastases2.350.2361.2590.155
Taxane-refractary0.9770.5661.6880.934
Grade 3–4 toxicities1.7230.9663.0720.065
  1. Abbreviations: OS overall survival, HR hazard ratio, CI confidence interval